Biotech Developing “Tissue Therapeutics” to Treat Diseased Organs Launches from BU and MIT Labs

Greater Boston has become the nation’s biotech hub—the Silicon Valley of life sciences, according to some—and Massachusetts is now reportedly home to more than 1,000 biotech companies, employing more than 80,000 people. One of the newest multimillion-dollar firms helping to drive the boom has its roots in a Boston University lab. Satellite Bio—fueled by technology codeveloped by BU biomedical engineer Christopher Chen—launched in April after announcing it had secured $110 million in venture funding.


Newly Named Allen Distinguished Investigators Aim to Recreate Lungs

The Paul G. Allen Family Foundation has awarded funding to a trio of BU faculty for a bold, early-stage project aimed at lab-grown lungs that mimic the real organ in all its fractal complexity. The proposal of Associate Professor Wilson Wong (BME), Professor Christopher Chen (BME, MSE), and School of Medicine Professor Darrell Kotton has […]

Tagged: , ,

AHA Moment: Lejeune Awarded Funding for Heart Cell Data Work

By Patrick L. Kennedy With a promising technology aimed at combating heart disease, Assistant Professor Emma Lejeune (ME) has earned the American Heart Association (AHA) Career Development Award. Lejeune’s software and computational methods have the potential to empower future researchers to develop medicine and artificial tissue that will cure cases of cardiac disease—the leading cause […]

Tagged: , ,